SCHEMBL9405656

SCHEMBL9405656

CC(CCCCCCCCC(=O)O)CCCCCCCCC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.60
LMNA P02545 2/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
FFAR4 Q5NUL3 2/20 0.57
FFAR1 O14842 2/20 0.57
ALDH1A1 P00352 3/20 0.55
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
PTPN1 P18031 3/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8054929 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL3138401 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL5710414 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL9405592 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL19940379 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL3137343 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL9405657 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL9405636 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL3829825 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4
SCHEMBL31015821 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-6290995-A None JP disclosed
US-20230256098-A1 BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS BANK OF AMERICA, N.A. 2023-08-17 US disclosed
JP-H06290995-A ELECTROLYTE FOR ELECTROLYTIC CAPACITOR MARCON ELECTRON CO LTD 1994-10-18 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230256098-A1 BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS LIPA, APOB, CETP TSHR 2733/4885LMNA 248/4885NFKB1 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.